Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.

Slides:



Advertisements
Similar presentations
Neoadjuvant therapy for Rectal cancer
Advertisements

Taunton SpR Training Day 7th December 2012 Early rectal cancer
Adjuvant chemotherapy in resectable liver-limited metastasis colorectal cancer 指導VS: 鄧豪偉 財團法人台灣癌症臨床研究發展基金會.
Management of Malignant Polyps Santhat Nivatvongs, MD Colon and Rectal Surgery Mayo Clinic Rochester Minnesota U.S.A.
Endoscopic Ultrasound in Rectal Cancer Natasha Schneider November 15, 2010.
AJCC Staging Moments AJCC TNM Staging 7th Edition Rectal Case #3 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Rectal Cancer: A Complete Clinical Response…Now what?
Great Debates & Updates in GI Malignancies
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
Management of colorectal cancer with liver metastasis Dr. Vivian Lee Department of Surgery, UCH.
Impact of the Type and Modalities of Preoperative Chemotherapy on the Outcome of Liver Resection for Colorectal Metastases R. Adam, E. Barroso, C. Laurent,
Joint Hospital Surgical Grand Round KL FOK NDH/AHNH Department of Surgery.
CRM (T stage) Low rectal cancer Nodal disease Risk Factors for Loc recurrence.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Management of GIST Dr Kwan Ming Wa Tuen Mun Hospital.
Management of Colorectal Liver Metastasis
Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.
Defining the Colorectal Surgeons role in patients with colorectal cancer and limited metastatic disease Jose G. Guillem, MD, MPH Department of Surgery.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
References 1.Salazar R, Roepman P, Capella G et al. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Multimodality Therapy of Cancer: Solid Tumour Treatment is a Team Sport! Principles of Surgery 2011 Andy Smith, MD Department of Surgery University of.
Treatment of Early Malignant Rectal Polyp
PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk;
Neoadjuvant Chemotherapy for Ca Breast CY Choi UCH.
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
Dept Surgery, Colorectal unit University Hospital, Uppsala, Sweden
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.
Resection For Lung Metastases M62 Coloproctology Course.
Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal. Eng C1, Rogers J2, Chang GJ3, You N3, Das P4, Rodriguez-Bigas.
Preoperative CCRT in Colorectal Cancer 嘉義長庚醫院 大腸直腸外科 葉重宏.
Role of EUS in colon lesions Pietro Fusaroli Gastroenterologia Università di Bologna.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Discussion abstracts Alberto Sobrero MD Ospedale San Martino Genoa, Italy.
Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Management of Lymph Node Metastases.
COLON CANCER A MAJOR ISSUE IN ALASKA. A common malignancy 200,000 cases in the U. S. in ,000 cases in the U. S. in 2008 Greater than 50 new cases.
Ultra-Low Sphincter Saving Procedures -
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
What is the Preferable Treatment Option for T1/T2 Low Rectal Cancer? Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology.
1 Recent trends in colorectal cancer in Norway: incidence, management and outcomes Arne Wibe, MD, PhD Professor of Surgery St. Olavs Hospital Trondheim,
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
TME trial TME radiotherapy 5 x 5 Gy TME alone randomisation n = 1861 resectable rectal carcinoma if CRM+: 50 GY.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
The treatment of metastatic squamous cell carcinoma (SCCA) of the anal canal: A single institution experience P. Pathak, B. King, A. Ohinata, P. Das, C.H.
Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.
Basingstoke Colorectal The Particular Problem of Low Rectal Cancer Brendan Moran Basingstoke 4 th East-West Colorectal Days Hungary 2008.
Results Abstract Analysis of Prognostic Web-based Models for Stage II and III Colon Cancer: A Population-based Validation of Numeracy and Adjuvant! Online.
Surgery of colorectal metastasis in the Optimox 1 study. A GERCOR Study. N. Perez-Staub, G. Lledo, F. Paye, B. Gayet, M. Flesch, A. Cervantes, A. Figer,
Role of MRI in Primary Rectal Cancer Staging and Management
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Operative Management of Osteosarcoma Patients with Pulmonary Metastasis Jen Kramer, MD R2 Swedish Medical Center February 2011.
Complete pathologic responses in the primary of rectal or colon cancer treated with FOLFOX without radiation A. Cercek, M. R. Weiser, K. A. Goodman, D.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
Karcinom rektuma- management
R. Michelle Sarin, MD Mentor: Jeffrey Fowler, MD
Surgical Treatment in Locally Advanced Prostate Cancer
盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全, 吳昆霖
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Adjuvant Therapy in Gastric Cancer: Radiation Therapy Adds Nothing!
Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.
Do all patients with T2-3 mid-high rectal adenocarcinomas require RT as part of their neoadjuvant therapy? - Yes - 
 Bruce Minsky.
Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD 
LOCAL EXCISION IN DOWNSTAGED T2T3 LOW RECTAL CANCER 5-year results of the GRECCAR 2 trial E Rullier, V Vendrely, P Rouanet, JJ Tuech, A Valverde, B Lelong,
Surgical resection of metachronous liver metastases
Presentation transcript:

Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering Cancer Center Great Debates & Updates in GI Malignancies March 28-29, 2014

Rectal Cancer Surgical Options Local Recurrence T 1 N 0 18%0% T 2 N 0 47%6% Mellgren et al. Dis Colon Rectum, 2000

Inadequacy of baseline ERUS staging of primary and LN disease StagePooled Sensitivity (%) Pooled Specificity (%) T T T T N+ (overall) N+ ( ) Puli SR et al. Ann Surg Oncol *Meta-analysis N = 2732 cases

Evaluated parameters Sensitivity (%)Specificity (%)Diagnostic Odds Ratio (%) T stage MRF involvement LN involvement Inadequacy of baseline MRI staging of primary, MRF, and LN involvement *Meta-analysis N = 1249 cases Al-Sukhni E et al. Ann Surg Oncol. 2012

6.4mm5.7mm ERUS Identification of N1 Disease Photomicrograph (x20, H&E) of a lymph node that is 70% replaced by tumor.

Micrometastatic Disease Photomicrograph (x20, H&E) of a lymph node with a 1mm tumor deposit

ERUS Lymph Node Staging is T Dependent StagenpN+ Median metastasis size (mm) ERUS Nodal Accuracy Specificity pT1216 (29%) pT %) pT %) pT421 (50%) All1347 (35%) Landman, et al Dis Col Rectum (2007)

TAE for T1 Rectal Cancer 1. High risk of ca recurrence vs. RAD. 2. TAE has a lower cancer cure rate. 3. Neither adjuvant therapy nor surgical salvage are reliable. Paty P et al Ann Surg 2002 Bentran D et al Ann Surg, 2005 Nash, G DCR, 2008

Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a surveillance, epidemiology, and end results (SEER) population-based study N = 13,262 pts with rectal cancer Surgery –3715 (28%) local excision –9547 (72%) major resection Preoperative clinical T staging –953 (7%) Tis –6223 (47%) T1 –6086 (46%) T2 Bhangu A et al. Annals of Surg

Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a surveillance, epidemiology, and end results (SEER) population-based study Bhangu A et al. Annals of Surg LEMajor resection Adjusted HRp value Tis OS CSS 76.% 95.1% 79% 96.2% T1 OS CSS 71.8% 92.3% 80.6% 94.4% < T2 OS CSS 63.1% 85.2% 75.6% 91.5% <0.001 *Estimated 5y OS and CSS

Local excision in early rectal cancer – outcome worse than expected: a population based study N = 3694 consecutive stage I rectal ca pts from Swedish Rectal Cancer Register 448 LE vs 3246 radical resection (Hartmann, LAR, APR) LE pts –LR 11.2% (vs ~3% for all radical procedures combined) –Relative survival 0.81 (95% CI ) Saraste D et al. Eur J Surg Oncol

Multimodality salvage of recurrent disease after local excision for rectal cancer You YN et al. Dis Colon Rectum y OS s/p salvage 63% 3y RFS s/p salvage 43% In salvage surgery R0 resection in 80%, Multivisceral 30%, neoadjuvant 70% Sphincter preservation in 33%

Salvage resection after local excision for rectal cancer Study, yearInitial surgery Initial stageSalvage surgery of curative intent, n Rate of R0 resection, % Rate of sphincter preservatio n, % Long-term (5-y) outcome, % MD Anderson, 2002 LET1, T DFS 59 MSKCC, 2005 LET1, T DFS 53 The Netherlands, 2010 TEMS protocol T DSS (3-y) 58 Rome, 2012TEMS protocol T1, T2, T OS 62 MD Anderson 2012 LET1, T2, T OS 68; RFS (3-y) 43

Predicting lymph node metastases in early rectal cancer N = 677 pts with pT1-2 rectal Ca in the Swedish Rectal Cancer Register Saraste D et al. Eur J Cancer Multivariate analysis OR 95% CI (Ref 1) T21.97( ) Poor differentiation6.47( ) Vascular infiltration4.34( )

Predicting lymph node metastases in early rectal cancer Saraste D et al. Eur J Cancer

Preoperative Considerations if Pursuing a Sphincter Preserving Resection Determination is both preop and intraop Body habitus, sphincter mass? Sphincter tone, squeeze? Co-morbidities? Patient expectations, enthusiasm? Understands the “good news/bad news” post operative scenario.

As in fly fishing…“Match the Hatch” “Match the Disease” Should be the governing paradigm in the management of rectal cancer J Guillem, Ann Surg 2007